Bisacodyl Suppository
NDC Package 83720-550-25
Package Information
Bisacodyl (bisacodyl suppositories) suppositories is - tear off one suppository from the strip- peel apart the wrapper- continue peeling apart to almost the full length of the suppository- gently remove the suppository from the wrapper- lie on your side and push suppository, with pointed end first, high into the rectum so it will not slip out- retain it for 15 to 20 minutes- Do not exceed recommended dose- if suppository seems soft, place in refrigerator for a short time before use. Adults and children 12 years and over 1 suppository once daily Children 6 to under 12 years 1/2 suppository once daily Children under 6 years Ask a doctor. This formulation utilizes a suppository delivery system. Marketed by Oncor Pharmaceuticals, this product is identified by NDC 83720-550 and is authorized under FDA application M007.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83720 - Oncor Pharmaceuticals
- 83720-550 - Bisacodyl
- 83720-550-25 - 12 SUPPOSITORY in 1 CARTON
- 83720-550 - Bisacodyl
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83720-550-25 identifies a specific commercial package of 12 suppository in 1 carton of Bisacodyl, a human over the counter drug labeled by Oncor Pharmaceuticals. This suppository is formulated for rectal use and contains bisacodyl as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Oncor Pharmaceuticals on February 01, 2025. The current certification is valid through December 31, 2026.
How is this Oncor Pharmaceuticals product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83720055025. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.